| Database ID | Agent | Target | Cancer Type | Detail |
| DB00271 | afatinib | Receptor proteintyrosine kinase erbB2
Epidermal growth factor receptor | head and neck cancer | view |
| DB00272 | PX866 | PI3K gamma | colorectal cancer or head and neck cancer | view |
| DB00273 | EMD 1201081 | Tolllike receptor 9 | head and neck cancer | view |
| DB00274 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00275 | cilengitide | ¦Áv¦Â3 and ¦Áv¦Â5 integrins | head and neck cancer | view |
| DB00276 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00277 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00278 | cetuximab | Epidermal growth factor receptor | esophagusgastroesophageal junction cancer | view |
| DB00279 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00280 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00281 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00282 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00283 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00284 | erlotinib | Epidermal growth factor receptor | head and neck cancer | view |
| DB00285 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |